Medical doctor Douglas Sato gave lecture at Tohoku University event
School of Medicine professor and Superintendent of Teaching, Research and Development of the Brain Institute of RS, Dr Douglas Sato, was the only medical doctor from Brazil invited to Sendai Conference 2018, in Tokyo, Japan. The event was offered by Tohoku University, in July, and brought together neurologists from all over the world at TKP Garden City Sendai for a series of lectures in the area of neurology.
In his lecture, Dr Sato discussed the central theme of the investigations he has been working on for the last seven years involving neurological patients whose symptoms match those of the demyelinating disease of central nervous system and are positive for anti-MOG antibody. He has also suggested an acronym, for a new “disease” known as MONEM (MOG-IgG-associated Optic Neuritis).
Glossary
Demyelinating disease of central nervous system – diseases that cause the individual’s own immune system to cause inflammations in the brain and in the spinal cord. These focal brain injuries cause damages to nerve conduction. Among such diseases, the most common one is multiple sclerosis, but several others may cause similar symptoms.
MONEM – Several biomarkers are investigated in order for medical doctors to diagnose the health conditions. These include the antibody against oligodendrocyte glycoprotein (MOG-IgG) that has been studied intensively by Dr Douglas Sato. His research group has suggested the term MONEM (MOG-IgG associated optic neuritis, encephalitis, and/or myelitis), as it encompasses the clinical conditions that are positive for MOG-IgG in international articles and event.
